Liposomes
are effective nanocarriers due to their ability to encapsulate
and deliver a wide variety of therapeutics. However, therapeutic potential
would be improved by enhanced control over the release of drug cargo.
Zinc ions provide exciting new targets for stimuli-responsive lipid
design due to their overly abundant concentrations associated with
diseased cells. Herein, we report zinc-triggered release of liposomal
contents exploiting synthetic lipid switches designed to undergo conformational
changes in the presence of this ion. Initially, Nile red leakage assays
were conducted that validated successful dose-dependent triggering
of release using zinc-responsive lipids (ZRLs). In addition, dynamic
light scattering and confocal microscopy experiments showed that zinc
treatment led to morphological changes in lipid nanoparticles only
when ZRLs were present in formulations. Next, zinc-binding experiments
conducted in a solution (NMR, MS) or membrane (zeta potential) context
confirmed ZRL-Zn complexation. Finally, polar cargo release from liposomes
was achieved. The results from these wide-ranging experiments using
four different compounds indicated that zinc-responsive properties
varied based on ZRL structure, providing insights into the structural
requirements for activity. This work has established zinc-responsive
liposomal platforms toward the development of clinical triggered release
formulations.